NMO-IgG binding to AQP4 in astrocytes is thought to initiate a cascade of inflammatory events, including antibody-dependent complement and cell-mediated astrocyte damage, leukocyte recruitment, cytokine release and demyelination [1], [21], [22]. Here, AQP4 is linked to neuromyelitis optica.